Overview
Status
Active
Registry date
2017-02-23
Share capital
5,000.00 PLN
Registered address
ul. Józefa Elsnera 34, 02-680 Warszawa, Poland
Email
Electronic delivery address
AE:PL-81576-93229-JJVSU-19
Financials
Revenue history (in k)
Filing timeliness
3 of 6 financial statements were filed late (the longest delay 79 days for 2021).
- 202515/07/2026
- 202414/07/2025
- 202308/04/2024
- 202201/10/2023
- 202102/10/2022
- 202018/10/2021
Filed on timeDelayFiling deadline
Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.
Statistics
How the company ranks by revenue within its industry, region and across Poland in 2025.
Results vs industry
Revenue
This companyUSD 24.64kMedianUSD 307.38kAverageUSD 2.27m
Net profit
This companyUSD -6.73kMedianUSD 3.26kAverageUSD 112.07k
Operating costs
This companyUSD 29.77kMedianUSD 296.42kAverageUSD 2.08m
Assets
This companyUSD 8.83kMedianUSD 182.33kAverageUSD 1.55m
Industry
Authorized Representatives
Daniela Shryvastava – President of the Management Board
Irina Shrivastava – Management Board Member
Manner of representation
Each member of the management board is authorized to make declarations on behalf of the company independently.
Ownership
| Owner | Shares | Share value | Stake |
|---|---|---|---|
Irina Shrivastava | 1 | $675.31 | 50% |
Daniela Shryvastavaage 30 | 1 | $675.31 | 50% |
Beneficial owners
| Person | Rights |
|---|---|
Bank accounts
Registered as a VAT taxpayer on 2017-06-25.
02 1050 1025 1000 0090 3144 5498
03 1050 1025 1000 0090 3144 5480
77 1050 1025 1000 0090 3144 5506
Debt
No entries in the National Debtors Register (KRZ).
Public aid
| Grant date | Purpose | Gross amount | Granting body | |
|---|---|---|---|---|
| Jun 9, 2020 | Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts | $1,282$1,282 | Prezydent Miasta Stołecznego Warszawy |
Competitors
| Name | Revenue | Website | ||
|---|---|---|---|---|
| Hugehalls GroupS.A. | $16,791,488.58 | hugehalls.com | ||
| SEMA Groupsp. z o.o. | $844,621.51 | sema-group.pl | ||
| Street Hypesp. z o.o. | $624,718.47 | shstore.eu | ||
| KnitersP.S.A. | $366,895.92 | kniters.com | ||
| Ulabeesp. z o.o. | $49,319.60 | ulabee.pl | ||
| ŁYKOsp. z o.o. | $39,912.71 | lykowarsaw.pl | ||
| Ewestasp. z o.o. | $22,513.17 | e-westa.com | ||
| Maremisp. z o.o. | $0.00 | maremidesign.pl | ||
| Harper HygienicsS.A. | – | harperhygienics.com | ||
| Altivo Artsp. z o.o. | – | altivoart.pl |
FAQ
The main business activity of Greenlife Biosciences focuses on manufacture of made-up textile articles, except apparel.
The company was registered in the Polish National Court Register (KRS) on February 23, 2017.
The headquarters is located at: ul. Józefa Elsnera 34, 02-680 Warszawa.
The management board includes Daniela Shryvastava (President of the Management Board).
The share capital of the company is PLN 5,000 (approx. $1,351).
The latest available financial statement covers the period from January 1, 2025 to December 31, 2025.
The company reported a revenue of $24,638 in 2025, which is a decrease of 14.2% compared to 2024.
No, in 2025 the company was not profitable, reporting a net loss of $6,726. For comparison, in 2024 the loss was $5,040, meaning the company increased its loss by 33.2%.
The largest operating cost category falls under materials and energy. This category amounted to $16,306 in 2025, representing 55% of all operating expenses.
Last updated: 2026-07-15